ALAN KIVITZ MD NPI 1447259023

NPI Information

  • NPI: 1447259023
  • Provider Name: ALAN KIVITZ, MD
  • Classification: Internal Medicine - 207RR0500X
  • Specialization: Rheumatology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 175 MEADOWBROOK LN
    DUNCANSVILLE, PA
    ZIP 16635
  • Phone: (814) 693-0300

Map and Directions

Get Directions

NPI Details

Alan Kivitz, MD is a rheumatology internal medicine in Duncansville, PA with 44 years of experience. The provider is an internist who treats diseases of joints, muscle, bones and tendons. This specialist diagnoses and treats arthritis, back pain, muscle strains, common athletic injuries and collagen diseases. Alan Kivitz, MD NPI is 1447259023. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: ALBANY MEDICAL COLLEGE OF UNION UNIVERSITY
Graduation Year:1982

The provider's business location address is:

175 MEADOWBROOK LN
DUNCANSVILLE, PA
ZIP 16635-445
Phone: (814) 693-0300
Fax: (814) 693-0400

The NPI 1447259023 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0717)
  • Injection, tocilizumab, 1 mg (HCPCS:J3262)
  • Injection, golimumab, 1 mg, for intravenous use (HCPCS:J1602)
  • Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS:J0129)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg (HCPCS:J3304)
  • Injection, rituximab, 10 mg (HCPCS:J9312)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Blood creatinine level (HCPCS:82565)
  • Liver enzyme (sgot), level (HCPCS:84450)
  • Liver enzyme (sgpt), level (HCPCS:84460)
  • Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
  • Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
  • Hyaluronan or derivative, hymovis, for intra-articular injection, 1 mg (HCPCS:J7322)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Measurement of antibody for assessment of autoimmune disorder, any method (HCPCS:86235)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Albumin (protein) level (HCPCS:82040)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Aspiration and/or injection of fluid from large joint (HCPCS:20610)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
  • Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
  • X-ray of hand, minimum of 3 views (HCPCS:73130)
  • Measurement of complement (immune system proteins), antigen, (HCPCS:86160)
  • Vitamin d-3 level (HCPCS:82306)
  • Thyroxine (thyroid chemical), free (HCPCS:84439)
  • Phosphate level (HCPCS:84100)
  • Cardiolipin antibody (tissue antibody) measurement (HCPCS:86147)
  • Measurement of dna antibody, native or double stranded (HCPCS:86225)
  • Calcium level, total (HCPCS:82310)
  • Manual urinalysis test with examination using microscope, automated (HCPCS:81001)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Tuberculosis test, gamma interferon (HCPCS:86480)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Parathormone (parathyroid hormone) level (HCPCS:83970)
  • Rheumatoid factor level (HCPCS:86431)
  • X-ray of knee, 3 views (HCPCS:73562)
  • Uric acid level, blood (HCPCS:84550)
  • Screening test for autoimmune disorder (HCPCS:86038)
  • Measurement of antibody for assessment of autoimmune disorder, titer (HCPCS:86039)
  • Dxa bone density measurement of hip, pelvis, spine including spine fracture assessment (HCPCS:77085)
  • Crystal identification from tissue or body fluid (HCPCS:89060)
  • Body fluid cell count with cell identification (HCPCS:89051)
  • Blood viscosity measurement (HCPCS:85810)
  • Joint fluid diagnostic test (HCPCS:83872)
  • X-ray of pelvis, 1-2 views (HCPCS:72170)
  • Measurement of antibody for rheumatoid arthritis assessment (HCPCS:86200)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • X-ray of foot, minimum of 3 views (HCPCS:73630)
  • Hepatitis c antibody measurement (HCPCS:86803)
  • Detection test by immunoassay technique for hepatitis b surface antigen (HCPCS:87340)
  • Hepatitis b surface antibody measurement (HCPCS:86706)
  • Creatine kinase (cardiac enzyme) level, total (HCPCS:82550)
  • Hepatitis b core antibody measurement (HCPCS:86704)
  • Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
  • Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • X-ray of shoulder, minimum of 2 views (HCPCS:73030)
  • X-ray of lower and sacral spine, minimum of 4 views (HCPCS:72110)
  • X-ray of chest, 2 views (HCPCS:71046)
  • Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
  • Microsomal antibodies (autoantibody) measurement (HCPCS:86376)
  • Administration of influenza virus vaccine (HCPCS:G0008)
  • Thyroglobulin (thyroid protein) antibody measurement (HCPCS:86800)
  • Analysis of substance using immunoassay technique, multiple step method (HCPCS:83516)
  • Gammaglobulin (immune system protein) measurement (HCPCS:82784)
  • Iron level (HCPCS:83540)
  • Iron binding capacity (HCPCS:83550)
  • Ferritin (blood protein) level (HCPCS:82728)
  • Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
  • Aspiration and/or injection of fluid from small joint (HCPCS:20600)
  • Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
  • Dxa bone density measurement of hip, pelvis, spine (HCPCS:77080)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Analysis for antibody borrelia burgdorferi (lyme disease bacteria) (HCPCS:86618)
  • Fee covid-19 vac 14 res (HCPCS:0134A)
  • Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
  • X-ray of upper spine, 4-5 views (HCPCS:72050)
  • Mri scan of lower spinal canal without contrast (HCPCS:72148)
  • Hyaluronan or derivative, gel-one, for intra-articular injection, per dose (HCPCS:J7326)
  • X-ray of spine, 1 view (HCPCS:72020)
  • Glutamyltransferase (liver enzyme) level (HCPCS:82977)
  • Injection, methylprednisolone sodium succinate, up to 125 mg (HCPCS:J2930)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Influenza vaccine, quadrivalent derived from cell cultures (HCPCS:90756)
  • Blood glucose (sugar) level (HCPCS:82947)
  • Injection into tendon or ligament (HCPCS:20550)
  • Mri scan of leg joint without contrast (HCPCS:73721)
  • Adm sarscov2 100mcg/0.5ml3rd (HCPCS:0013A)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Folic acid level, serum (HCPCS:82746)
  • Magnesium level (HCPCS:83735)
  • Red blood count, manual test (HCPCS:85044)
  • Mri scan of arm joint without contrast (HCPCS:73221)
  • Aspiration and/or injection of fluid from medium joint (HCPCS:20605)
  • X-ray of middle spine, 2 views (HCPCS:72070)
  • Mri scan of arm before and after contrast (HCPCS:73220)
  • Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
  • Mri scan of pelvis without contrast (HCPCS:72195)

The enumeration date for this NPI number is 7/18/2005 and was last updated on 4/27/2017.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RR0500XInternal MedicineRheumatologyMD026744EPENNSYLVANIAYes

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.

No. Other Provider Identifier Other Provider Identifier Type Other Provider Identifier State Other Provider Identifier Issuer
1338517OTHERPENNSYLVANIABLUE SHEILD
2035542MEDICARE ID-TYPE UNSPECIFIED
31007706880003MEDICAIDPENNSYLVANIA
4B34867MEDICARE UPIN

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.